Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Redekop

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|February 6, 2018
What are the images used to diagnose and assess suspected strokes?: A systematic literature review of care in four European countriesAnne-Claire Peultier, Ken Redekop, Emmanuel Coche, et al.
Pharmacoeconomics|February 25, 2018
Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment StrategyAmir Ansaripour, Carin A Uyl-de Groot, W Ken Redekop
Health Economics|January 11, 2008
Costs and prices of single dental fillings in Europe: a micro-costing studySiok Swan Tan, W Ken Redekop, Frans F H Rutten
Pharmacoeconomics|November 5, 2003
The cost effectiveness of Apligraf treatment of diabetic foot ulcersW Ken Redekop, Joseph McDonnell, Paul Verboom, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 14, 2011
Long-term outcomes of continuous intrathecal baclofen infusion for treatment of spasticity: a prospective multicenter follow-up studyElmar M Delhaas, Nicoline Beersen, W Ken Redekop, et al.
Pharmacoeconomics - Open|December 19, 2023
Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in DenmarkMilanne Maria Johanna Galekop, Carin Uyl-de Groot, William Ken Redekop
Patient Preference and Adherence|September 23, 2010
Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approachDavid S Cobden, Louis W Niessen, Frans Fh Rutten, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30Annemieke van Dongen-Leunis, W Ken Redekop, Carin A Uyl-de Groot
Pharmacoeconomics|June 9, 2020
Future of Data Analytics in the Era of the General Data Protection Regulation in EuropeKatarzyna Kolasa, W Ken Redekop, Alexander Berler, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
A Systematic Review of Cost-Effectiveness Studies of Interventions With a Personalized Nutrition Component in AdultsMilanne M J Galekop, Carin A Uyl-de Groot, W Ken Redekop
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Expert Review of Pharmacoeconomics & Outcomes Research|February 6, 2018
What are the images used to diagnose and assess suspected strokes?: A systematic literature review of care in four European countriesAnne-Claire Peultier, Ken Redekop, Emmanuel Coche, et al.
Pharmacoeconomics|February 25, 2018
Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment StrategyAmir Ansaripour, Carin A Uyl-de Groot, W Ken Redekop
Health Economics|January 11, 2008
Costs and prices of single dental fillings in Europe: a micro-costing studySiok Swan Tan, W Ken Redekop, Frans F H Rutten
Pharmacoeconomics|November 5, 2003
The cost effectiveness of Apligraf treatment of diabetic foot ulcersW Ken Redekop, Joseph McDonnell, Paul Verboom, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 14, 2011
Long-term outcomes of continuous intrathecal baclofen infusion for treatment of spasticity: a prospective multicenter follow-up studyElmar M Delhaas, Nicoline Beersen, W Ken Redekop, et al.
Pharmacoeconomics - Open|December 19, 2023
Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in DenmarkMilanne Maria Johanna Galekop, Carin Uyl-de Groot, William Ken Redekop
Patient Preference and Adherence|September 23, 2010
Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approachDavid S Cobden, Louis W Niessen, Frans Fh Rutten, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30Annemieke van Dongen-Leunis, W Ken Redekop, Carin A Uyl-de Groot
Pharmacoeconomics|June 9, 2020
Future of Data Analytics in the Era of the General Data Protection Regulation in EuropeKatarzyna Kolasa, W Ken Redekop, Alexander Berler, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
A Systematic Review of Cost-Effectiveness Studies of Interventions With a Personalized Nutrition Component in AdultsMilanne M J Galekop, Carin A Uyl-de Groot, W Ken Redekop
Pageof 9